Share on StockTwits

Equities research analysts at William Blair initiated coverage on shares of Imprivata (NASDAQ:IMPR) in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.

IMPR has been the subject of a number of other recent research reports. Analysts at JPMorgan Chase & Co. initiated coverage on shares of Imprivata in a research note on Monday. They set an “overweight” rating and a $19.00 price target on the stock. Analysts at Piper Jaffray initiated coverage on shares of Imprivata in a research note on Monday. They set an “overweight” rating and a $20.00 price target on the stock.

Imprivata (NASDAQ:IMPR) traded down 3.26% on Monday, hitting $16.00. The stock had a trading volume of 20,905 shares. Imprivata has a 52 week low of $15.40 and a 52 week high of $17.49. The stock’s 50-day moving average is $16.24 and its 200-day moving average is $16.24. The company’s market cap is $365.0 million.

Imprivata Inc is a provider of authentication and access management technology solutions for the healthcare industry.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.